Financial Enhancement Group LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Financial Enhancement Group LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2022$3,000
-25.0%
450.0%0.00%0.0%
Q2 2022$4,0000.0%450.0%0.00%0.0%
Q1 2022$4,000
+33.3%
45
+21.6%
0.00%0.0%
Q3 2020$3,0000.0%370.0%0.00%0.0%
Q2 2020$3,0000.0%370.0%0.00%0.0%
Q1 2020$3,000
-25.0%
370.0%0.00%0.0%
Q4 2019$4,000
+33.3%
370.0%0.00%0.0%
Q3 2019$3,0000.0%370.0%0.00%0.0%
Q2 2019$3,000
-87.5%
37
-85.0%
0.00%
-85.7%
Q1 2019$24,0002470.01%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders